person

Jean-Baptiste D.

Country
France
Department
Ophtalmology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
2
Sites with multiple studies

Has run more than one trial at 2 of 17 partner sites.

Specializations

Ophthalmic Research

This investigator specializes in researching age-related macular degeneration (AMD), with particular emphasis on treating advanced forms of the condition. Their work focuses on innovative therapeutic approaches for managing geographic atrophy (GA), a severe manifestation of AMD.

  • Advanced AMD Management
  • Geographic Atrophy Treatment
  • Retinal Degenerative Disorders

The investigator examines both oral medications and advanced therapeutic interventions for treating macular degeneration.

Therapeutic Innovation

Their research encompasses evaluation of novel therapeutic agents including dimethyl fumarate and investigational products like GT005 for ocular conditions. The investigator's work includes assessment of long-term treatment outcomes in patients with progressive retinal conditions.

  • Novel Drug Development
  • Long-term Safety Studies
  • Progressive Disease Management

The focus extends to developing sustained therapeutic approaches for chronic ocular conditions.

Clinical Outcomes

The investigator studies disease progression patterns in retinal degenerative disorders, with specific attention to measuring and tracking changes in geographic atrophy areas. Their research includes evaluation of treatment safety and efficacy over extended periods.

  • Disease Progression Analysis
  • Treatment Response Monitoring
  • Long-term Patient Outcomes

Their work encompasses comprehensive assessment of ocular and systemic treatment effects.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.